In AP, especially in obesity-associated AP, FABP4 upregulates UCP2, which in turn reduces oxidative stress to modulate macrophage signaling and inflammatory responses (Dierendonck et al. 2020; Steen et al. 2017). Here, FABP4 is linked to alkaline phosphatase measurement.